CS logo
small CS logo
Clinique Tivoli; Sce Radiotherapie

Bordeaux, France
Medical clinic in Bordeaux
220 Rue Mandron, 33000 Bordeaux

About Clinique Tivoli; Sce Radiotherapie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Clinique Tivoli; Sce Radiotherapie


During the past decade, Clinique Tivoli; Sce Radiotherapie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Tivoli; Sce Radiotherapie" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Clinique Tivoli; Sce Radiotherapie


According to Clinical.Site data, the most researched conditions in "Clinique Tivoli; Sce Radiotherapie" are "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Clinique Tivoli; Sce Radiotherapie" in a lesser frequency.

Clinical Trials Intervention Types at Clinique Tivoli; Sce Radiotherapie


Most popular intervention types in "Clinique Tivoli; Sce Radiotherapie" are "Drug" (10 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (4 trials), "Trastuzumab" (3 trials), "Atezolizumab" (2 trials), "Docetaxel" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Clinique Tivoli; Sce Radiotherapie


The vast majority of trials in "Clinique Tivoli; Sce Radiotherapie" are 7 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Clinique Tivoli; Sce Radiotherapie


Currently, there are NaN active trials in "Clinique Tivoli; Sce Radiotherapie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Clinique Tivoli; Sce Radiotherapie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinique Tivoli; Sce Radiotherapie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".